Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M508342200 on December 22, 2005

J. Biol. Chem., Vol. 281, Issue 8, 4663-4670, February 24, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplmental Data
Right arrow All Versions of this Article:
281/8/4663    most recent
M508342200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, V. A.
Right arrow Articles by Levine, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, V. A.
Right arrow Articles by Levine, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Apoptotic Cells, at All Stages of the Death Process, Trigger Characteristic Signaling Events That Are Divergent from and Dominant over Those Triggered by Necrotic Cells

IMPLICATIONS FOR THE DELAYED CLEARANCE MODEL OF AUTOIMMUNITY*Formula

Vimal A. Patel{ddagger}, Angelika Longacre{ddagger}, Kevin Hsiao§, Hanli Fan{ddagger}, Fanyong Meng{ddagger}, Justin E. Mitchell, Joyce Rauch||, David S. Ucker, and Jerrold S. Levine{ddagger}1

From the {ddagger}Department of Medicine, Division of Nephrology, University of Illinois at Chicago, Chicago, Illinois 60612, §Promega Corporation, Madison, Wisconsin 53711, the ||Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada, and the Department of Immunology and Microbiology, University of Illinois at Chicago, Chicago, Illinois 60612

Current models of autoimmunity suggest that delayed clearance of apoptotic cells leads to the presentation of apoptotic antigens in the context of inflammatory signals, with resultant autoimmunity. These models implicitly assume that, in contrast to early apoptotic cells (that retain membrane integrity), late apoptotic cells (with compromised membranes) act like necrotic cells (which also lack intact membranes), possibly because of the release of proinflammatory intracellular contents. We showed previously that early apoptotic and necrotic cells induce distinct mitogen-activated protein kinase modules in macrophages with which they interact. Exposure to apoptotic cells led to nearly complete inhibition of both basal and macrophage colony-stimulating factor-induced ERK1/2 by macrophages. In contrast, necrotic cells induced ERK1/2. We show here that apoptotic cells also strongly induced both c-Jun N-terminal kinase and p38, whereas necrotic cells had no detectable effect on c-Jun N-terminal kinase and p38. We also compared the signaling events induced in macrophages by exposure to early apoptotic cells, late apoptotic cells, and necrotic cells. The signaling events induced by late apoptotic cells were identical to and just as potent as those induced by early apoptotic cells. Thus, apoptotic cells are functionally equivalent throughout the cell death process, irrespective of membrane integrity. Moreover, the effects of both early and late apoptotic cells on signaling were dominant over those of necrotic cells. These data show that apoptotic cells do not become proinflammatory upon the loss of membrane integrity and are inconsistent with the notion that delayed clearance alone can lead to autoimmunity.


Received for publication, July 29, 2005 , and in revised form, December 21, 2005.

* This work was supported by National Institutes of Health Grants DK59793 and HL69722 (to J. S. L.) and AG024234 (to D. S. U.), by operating grants from the Arthritis Society of Canada (to J. R.) and the Canadian Institutes of Health Research (to J. R.), and by a Young Investigator Award from the National Kidney Foundation of Illinois (to J. S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S6.

1 To whom correspondence should be addressed: Dept. of Medicine/Division of Nephrology, MC793, 820 S. Wood St., University of Illinois at Chicago College of Medicine, Chicago, IL 60612. Tel.: 312-413-1178; Fax: 312-996-7378; E-mail: jslevine{at}uic.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. C. Todt, B. Hu, and J. L. Curtis
The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages
J. Leukoc. Biol., August 1, 2008; 84(2): 510 - 518.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. L. Curtis, C. M. Freeman, and J. C. Hogg
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Proceedings of the ATS, October 1, 2007; 4(7): 512 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. M. Kinchen and K. S. Ravichandran
Journey to the grave: signaling events regulating removal of apoptotic cells
J. Cell Sci., July 1, 2007; 120(13): 2143 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-P. Liang, S. Han, T. Senokuchi, and A. R. Tall
The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis
Circ. Res., June 8, 2007; 100(11): 1546 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. G. Freire-de-Lima, Y. Q. Xiao, S. J. Gardai, D. L. Bratton, W. P. Schiemann, and P. M. Henson
Apoptotic Cells, through Transforming Growth Factor-beta, Coordinately Induce Anti-inflammatory and Suppress Pro-inflammatory Eicosanoid and NO Synthesis in Murine Macrophages
J. Biol. Chem., December 15, 2006; 281(50): 38376 - 38384.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Lucas, L. M. Stuart, A. Zhang, K. Hodivala-Dilke, M. Febbraio, R. Silverstein, J. Savill, and A. Lacy-Hulbert
Requirements for Apoptotic Cell Contact in Regulation of Macrophage Responses
J. Immunol., September 15, 2006; 177(6): 4047 - 4054.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Cvetanovic, J. E. Mitchell, V. Patel, B. S. Avner, Y. Su, P. T. van der Saag, P. L. Witte, S. Fiore, J. S. Levine, and D. S. Ucker
Specific Recognition of Apoptotic Cells Reveals a Ubiquitous and Unconventional Innate Immunity
J. Biol. Chem., July 21, 2006; 281(29): 20055 - 20067.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Mitchell, M. Cvetanovic, N. Tibrewal, V. Patel, O. R. Colamonici, M. O. Li, R. A. Flavell, J. S. Levine, R. B. Birge, and D. S. Ucker
The Presumptive Phosphatidylserine Receptor Is Dispensable for Innate Anti-inflammatory Recognition and Clearance of Apoptotic Cells
J. Biol. Chem., March 3, 2006; 281(9): 5718 - 5725.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement